XM tillhandahåller inte tjänster till personer bosatta i USA.
M
M

McCormick


Nyheter

What to Watch in the Week Ahead and on Monday, June 24

What to Watch in the Week Ahead and on Monday, June 24 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT ON MONDAY Federal Reserve Bank of San Francisco President Mary Daly will likely speak on monetary policy and the economy at an event in partnership with the Commonwealth Club World Affairs of
N
T
W
M

U.S. earnings week ahead

DIARY-U.S. earnings week ahead June 21 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. ** Please Note - All times given are in U.S. EDT unless otherwise stated ** U.S. EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 25-Jun-2024 AMC FDX FedEx Corp Q4 2024 FedEx Corp Earnings Release 25-Jun-2024 AMC JNPR Juniper Networks Inc Q2 2024 Preliminary Juniper Networks Inc Earnings Release 26-Jun-2024 AMC MU.O Micron Technology Inc Q3 2024 Micron Technology Inc Ear
M
N
P
W
U
M

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
K
M
N
C
C
D
M

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
K
M
N
U
T
C
C
D
M

U.S. BioNTech, Honeywell International, Klaviyo

U.S. RESEARCH ROUNDUP-BioNTech, Honeywell International, Klaviyo June 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biontech, Honeywell International and Klaviyo, on Wednesday. HIGHLIGHTS * BioNTech SE BNTX.O : JP Morgan raises target price to $94 from $90 * Honeywell International Inc HON.O : HSBC raises target price to $235 from $200 * Klaviyo Inc KVYO.N : Barclays raises to overweight from equal weight * NetA
A
F
G
N
R
G
D
M

Mccormick Appoints Valarie Sheppard To Board Of Directors

BRIEF-Mccormick Appoints Valarie Sheppard To Board Of Directors May 21 (Reuters) - McCormick & Company Inc MKC.N : MCCORMICK APPOINTS VALARIE SHEPPARD TO BOARD OF DIRECTORS Source text for Eikon: ID:nPn3mWK4Za Further company coverage: MKC.N
M

U.S. Conocophillips, Fastly, Vital Energy

U.S. RESEARCH ROUNDUP-Conocophillips, Fastly, Vital Energy April 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Conocophillips, Fastly and Vital Energy, on Monday. HIGHLIGHTS * Broadcom Inc AVGO.O : Deutsche Bank resumes coverage with buy rating; price target $1500 * Conocophillips COP.N : Gerdes Energy Research cuts to neutral from buy * Fastly Inc FSLY.N : Piper Sandler raises to overweight from neutral * Shockw
A
B
B
C
C
G
H
N
V
A
B
A
A
A
A
C
C
H
M

Cognizant Signs A Global Infrastructure Agreement With McCormick & Company

BRIEF-Cognizant Signs A Global Infrastructure Agreement With McCormick & Company April 2 (Reuters) - Cognizant Technology Solutions Corp CTSH.O : COGNIZANT SIGNS A LARGE, GLOBAL INFRASTRUCTURE AGREEMENT WITH MCCORMICK & COMPANY, INC. COGNIZANT TECHNOLOGY SOLUTIONS CORP - NEW AGREEMENT IS EXPECTED TO DELIVER PREDICTABLE BUSINESS OUTCOMES POWERED BY
C
M

U.S. Acuity Brands, CSG Systems International, Nuvation Bio

U.S. RESEARCH ROUNDUP-Acuity Brands, CSG Systems International, Nuvation Bio March 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Acuity Brands, CSG Systems International, and Nuvation Bio, on Wednesday. HIGHLIGHTS * Acuity Brands Inc AYI.N : Baird raises target price to $286 from $236 * CSG Systems International CSGS.O : RBC initiates coverage with outperform rating * Lenz Therapeutics Inc LENZ.O : Piper Sandler
N
V
D
T
I
M

Dow, S&P fall for third straight session with inflation data eyed

REFILE-US STOCKS-Dow, S&P fall for third straight session with inflation data eyed Adds dropped word in headline Tesla to give customers one-month driver-assist trial; shares up McCormick jumps after Q1 profit, sales beat Trump Media & Technology surges in debut after SPAC merger Indexes down: Dow 0.08%, S&P 500 0.28%, Nasdaq 0.42% By Chuck Mikolajczak NEW YORK, March 26 (Reuters) - U.S.
G
M
S
T
U
U
M

Wall St little changed as investors eye inflation data

US STOCKS-Wall St little changed as investors eye inflation data Tesla to give customers one-month driver-assist trial; shares up McCormick jumps after Q1 profit, sales beat Trump Media & Technology surges in debut after SPAC merger Updated at 4:00 a.m. ET/ 2000 GMT By Chuck Mikolajczak NEW YORK, March 26 (Reuters) - U.S. stocks were little changed on Tuesday , giving up modest gains late in the session, as investors awaited economic data in a holiday-shortened week to gauge the Federal Reserve'
G
M
S
T
U
U
M

Wall St gains as megacap growth stocks lead

US STOCKS-Wall St gains as megacap growth stocks lead Tesla to give customers one-month driver-assist trial; shares up McCormick jumps after Q1 profit, sales beat Trump Media & Technology surges on debut after SPAC merger Indexes up: Dow 0.22%, S&P 0.20%, Nasdaq 0.26% Updated at 2:05 a.m. ET/ 1805 GMT By Chuck Mikolajczak NEW YORK, March 26 (Reuters) - U.S.
G
S
T
U
U
M

U.S. STOCKS Nuvation Bio, Seagate, AppFolio

BUZZ-U.S. STOCKS ON THE MOVE-Nuvation Bio, Seagate, AppFolio Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes climbed on Tuesday as most heavyweight growth stocks and chipmakers rose, while investors looked forward to economic data in a holiday-shortened week to assess the Federal Reserve's policy path.
A
S
W
U
U
D
M

Wall St advances as chipmakers, megacap growth stocks rebound

US STOCKS-Wall St advances as chipmakers, megacap growth stocks rebound For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Tesla to give customers one-month driver-assist trial; shares up McCormick jumps after Q1 profit, sales beat Trump Media & Technology surges on debut after SPAC merger Indexes up: Dow 0.25%, S&P 0.29%, Nasdaq 0.38% Updated at 11:28 a.m.
M
M
S
T
U
U
M

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change Seagate Technology Holdings PLC STX.OQ +10.5% McCormick & Company Inc MKC.N +10% Western Digital Corp WDC.OQ +5.6% Tesla Inc TSLA.OQ +4.7% MGM Resorts International MGM.N +4.3% Bottom Performers Percent Change United Parcel Service Inc
D
H
T
W
C
U
M

U.S. STOCKS Reddit, CONSOL Energy, Nuvation Bio

BUZZ-U.S. STOCKS ON THE MOVE-Reddit, CONSOL Energy, Nuvation Bio Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes climbed on Tuesday as most megacap growth stocks and chipmakers advanced, while investors awaited economic data in a holiday-shortened week to assess the Federal Reserve's easing path.
H
S
W
U
U
D
M

Spice maker McCormick set for best session in a year on Q1 beat

BUZZ-Spice maker McCormick set for best session in a year on Q1 beat Updates ** Shares of Cholula hot sauce-maker McCormick & Co MKC.N up as much as 9.5 % a t $76 .61 - highest since Sept. 22 ** If gains hold, stock set for the best day since March 28, 2023 ** Co's Q1 adjusted EPS of 63 cents beats analysts' expectation of 58 cents, per LSEG data *
M

Wall St rises as chipmakers, megacap growth stocks recover

US STOCKS-Wall St rises as chipmakers, megacap growth stocks recover For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. McCormick jumps after Q1 profit, sales beat Trump Media & Technology surges on debut after SPAC merger Indexes up: Dow 0.18%, S&P 0.29%, Nasdaq 0.45% Updated at 09:33 a.m. ET/ 1333 GMT By Shashwat Chauhan and Bansari Mayur Kamdar March 26 (Reuters) - Wall Street's main stock indexes climbed on Tuesday as most megacap grow
M
N
T
U
U
M

Spice maker McCormick beats quarterly results on steady volumes, higher prices

UPDATE 1-Spice maker McCormick beats quarterly results on steady volumes, higher prices Adds shares in paragraph 1, CEO comment and forecast in paragraph 4, 9 March 26 - McCormick MKC.N beat market expectations for first-quarter sales and profit on Tuesday, as consumer demand for its high-priced spices and seasonings held amid sticky inflation , sending its shares up nearly 9% .
K
I
M

McCormick & Company Inc reports results for the quarter ended in February - Earnings Summary

McCormick & Company Inc reports results for the quarter ended in February - Earnings Summary McCormick & Company Inc MKC.N reported quarterly adjusted earnings of 63 cents​​ per share for the quarter ended in February, higher than the same quarter last year, when the company reported EPS of 59 cents. The mean expectation of twelve analysts for the quarter was for earnings of 58 cents per share.
M



Villkor

Populära tillgångar

Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.

Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.

Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.

Riskvarning: Ditt kapital riskeras. Hävstångsprodukter passar kanske inte alla. Se vår riskinformation.